35
2
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12398 |
MP7
PDK1 抑制剂,PDK1 inhibitor |
PDK | PI3K/Akt/mTOR signaling |
MP7 (PDK1 inhibitor) 是磷酸肌醇依赖性激酶-1 (PDK1) 抑制剂。 | |||
T24741 |
RS1-PDK1 inhibitor
RS-1,RS1,RS 1 |
PDK | PI3K/Akt/mTOR signaling |
RS1-PDK1 inhibitor (RS 1) 是一种选择性的蛋白激酶PDK1抑制剂,可用来治疗和预防疾病或失调。 | |||
T4046 |
BX517
PDK1 inhibitor 2,BX 517,BX-517 |
Akt; PDK | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
BX517 (PDK1 inhibitor 2) 是一种选择性 PDK1抑制剂,其 IC50=6 nM。 | |||
T16450 |
PDK1-IN-RS2
|
PDK | PI3K/Akt/mTOR signaling |
PDK1-IN-RS2 inhibits the activation of the downstream kinases S6K1 by PDK1. PDK1-IN-RS2 is a mimic of the peptide docking motif (PIFtide) and is a substrate-selective PDK1 inhibitor (Kd: 9 μM). | |||
T74814 |
PKM2/PDK1-IN-1
|
Others | Others |
PKM2/PDK1-IN-1 是一种紫草素硫醚衍生物,是PKM2/PDK1的双重抑制剂。 PKM2/PDK1-IN-1抑制NSCLC 细胞的增殖,并诱导细胞凋亡 (apoptosis)。 PKM2/PDK1-IN-1 诱导细胞间 ROS 产生,调节凋亡蛋白,参与线粒体和死亡受体通路。 | |||
T16670 |
PS210
|
PDK | PI3K/Akt/mTOR signaling |
PS210 是针对 PDK1的 PIF 结合口袋的、选择性的、有效的 PDK1激活剂,对其他蛋白激酶无活性。在细胞中,它的前药 PS423 可作为 PDK1的底物选择性抑制剂,抑制 S6K 的磷酸化和活化。 | |||
T1830 |
BX795
|
IκB/IKK; Chk; CDK; c-Kit; PDK; Autophagy | Autophagy; Cell Cycle/Checkpoint; NF-κB; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
BX795 是一种选择性PDK1抑制剂,也是相对特异性的TBK1和IKKɛ 抑制剂。它抑制 S6K1,Akt,PKCδ 和 GSK3β 的磷酸化,可调节自噬。 | |||
T1837 |
BX-912
|
Apoptosis; VEGFR; PKA; Chk; CDK; PDK | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
BX-912 是一种直接的,选择性的,ATP 竞争性的PDK1抑制剂,IC50值为 26 nM。它阻断肿瘤细胞 PDK1/Akt 信号转导,抑制多种肿瘤细胞株的锚定依赖性生长或诱导凋亡。 | |||
T2466 |
Osu03012
Osu-03012,Osu 03012,AR-12 |
PDK | PI3K/Akt/mTOR signaling |
Osu03012 (AR-12) 是一种口服生物可利用的小分子塞来昔布衍生的磷酸肌醇依赖性激酶 1(PDK1) 抑制剂,具有潜在的抗肿瘤活性。 | |||
T2348 |
GSK2334470
|
PDK | PI3K/Akt/mTOR signaling |
GSK2334470是一种高效的、特异性的PDK1抑制剂,IC50=10 nM。 | |||
T22350 |
JX06
|
Apoptosis; Dehydrogenase; PDK | Apoptosis; Metabolism; PI3K/Akt/mTOR signaling |
JX06 是一种选择性共价PDK 抑制剂,抑制PDK1,PDK2和PDK3,IC50值分别为 49 nM,101 nM 和 313 nM。它以不可逆的方式与半胱氨酸残基共价结合来抑制PDK1活性,具有抗肿瘤活性。 | |||
T3163 |
PS 48
|
PDK | PI3K/Akt/mTOR signaling |
PS 48 已被证明是一种 PKB 激酶 (PDK1) 激活剂 (Kd: 10.3 μM)。该化合物选择性地与 PKB 激酶 (PDK1) 的 PIF 结合口袋结合。 | |||
T24677 |
PS47
PS 47,PS-47 |
PDK | PI3K/Akt/mTOR signaling |
PS-47(PS 47) 是一种 PS48 的非活性 E-异构体。其中 PS48 是一种 PDK1 的激活剂。PS47 (PS 47) 可用作 PS48 的阴性对照。 | |||
T28218 |
NU6102
NU-6102,NU 6102 |
CDK | Cell Cycle/Checkpoint |
NU6102 是一种具有选择性和有效性的 ATP 竞争性 CDK2 抑制剂,具有抗肿瘤活性,对 CDK1/cyclinB、CDK2/cyclinA3、CDK1/CDK2、 CDK4、DYRK1A 、PDK1、ROCKII 具有抑制作用,可用于研究直肠癌。 | |||
T77685 |
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile
|
PDK | PI3K/Akt/mTOR signaling |
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile 是一种 PDK1 抑制剂,具有抗癌和抗增殖活性,可用来研究血管肉瘤、腺癌、多骨髓瘤、牛皮癣、前列腺癌和和阿尔茨海默病。 | |||
T12639 |
(R)-PS210
|
Others | Others |
(R)-PS210, the R enantiomer of PS210 is a substrate-selective allosteric PDK1 activator with an (AC50 of 1.8 μM). | |||
T12566 |
PS10
|
PDK | PI3K/Akt/mTOR signaling |
PS10 is a ATP-competitive inhibitor of pan-PDK(PDK2, PDK4, PDK1, and PDK3 with IC50 of 0.8 μM, 0.76 μM, 2.1 μM and 21.3 μM , respectively). | |||
T70911 |
PF-5177624
|
Others | Others |
PF-5177624 is a selective and potent PDK1 inhibitor inducing anti-tumor activity in breast cancer cells. | |||
T23495 |
UCN-01
|
Others | Others |
inhibitor of Akt, protein kinase C, PDK1 and cyclin-dependent kinases | |||
T2420 |
PHT-427
PHT 427,CS-0223 |
Apoptosis; Akt; PDK | Apoptosis; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
PHT-427 (CS-0223) 是一种 Akt 和 PDPK1双重抑制剂,与 Akt 和 PDPK1 中的 PH 结构域有亲和性,Ki 分别为 2.7 μM 和 5.2 μM。 | |||
T24676 |
PS423
PS210AM,PS 210 AM,PS 423,PS210-AM,PS-423 |
Others | Others |
PS423 is a substrate-selective protein kinase PDK1 inhibitor that acts by binding to the PIF-pocket allosteric docking site. | |||
T81788 |
Mito-SilylDCA
|
Others | Others |
Mito-SilylDCA 是一种针对线粒体网络中的 PDK1 的丙酮酸氢酶激酶抑制剂。这种化合物结合了具有靶向 TPP 部分的 DCA 分子,以及聚乙烯长链与硅基,以实现其对 PDK1 的抑制作用。 | |||
T24753 |
SA-16
SA 16 |
Others | Others |
SA-16 is a potent dual inhibitor of PDK1 and Aurora kinase. | |||
T10890 | CRTh2 antagonist 3 | Others | Others |
CRTh2 antagonist 3 is a powerful chemokine receptor homologous molecule expressed on Th2 cell (CRTh2) antagonists. CRTh2 antagonist 3 enhanced the activity of PDK1 on short peptide substrates with EC50 of 2 μM and Kd of 8.4 μM. CRTh2 antagonist 3 has the | |||
T60524 |
HIF-1α-IN-4
|
Others | Others |
HIF-1α-IN-4 是 HIF-1α抑制剂,在 HEK293T 细胞中的IC50值为 24 nM,具有潜在的抗肿瘤作用。 HIF-1α-IN-4 在缺氧条件下下调 VEGF 和 PDK1 mRNA 的表达。 | |||
T17224 |
VER-246608
|
Dehydrogenase; PDK | Metabolism; PI3K/Akt/mTOR signaling |
VER-246608 是ATP 竞争性的丙酮酸脱氢酶激酶抑制剂,对PDK-1,PDK-3,PDK-2,和PDK-4的IC50分别为 35 nM,40 nM,84 nM 和 91 nM。 | |||
T74830 |
PDK-IN-1
|
Others | Others |
PDK-IN-1(compound 7o)是一种针对丙酮酸脱氢酶激酶(PDK)的抑制剂,其对PDK1和HSP90的IC50值分别为0.03和0.1μM。通过靶向PDH/PDK轴,PDK-IN-1能有效降低肿瘤质量。 | |||
T37561 |
BX-320
|
Others | Others |
BX-320 is an inhibitor of the serine/threonine kinase 3-phosphoinositide-dependent protein kinase 1 (PDK1; IC50= 30 nM).1It is selective for PDK1 over a panel of 10 additional kinases (IC50s = >820 nM for all). BX-320 inhibits Akt and p70S6K1 phosphorylation in PC3 cells (IC50s = 1-3 μM). It induces apoptosis in, and inhibits the growth of, MDA-MB-468 breast cancer cells (IC50s = 0.5 and 0.6 μM, respectively), as well as inhibits cell growth in a panel of cancer cells (IC50s = 0.12-1.2 μM). BX-3... | |||
T60532 |
HIF-1α-IN-5
|
Others | Others |
HIF-1α-IN-5 是 HIF-1α的抑制剂,在 HEK293T 细胞中的 IC50值为 24 nM,也可抑制 MAO-A 的活性。 在缺氧条件下, HIF-1α-IN-5可下调 VEGF 和 PDK1 mRNA 的表达。HIF-1α-IN-5 具有用于癌症研究的潜力。 | |||
T38263 |
TBK1/IKKε-IN-4
TBK1/IKKε-IN-4 |
Others | Others |
TBK1/IKKε-IN-4 is a 6-aminopyrazolopyrimidine derivative and a potent, selective TBK1 and IKKε inhibitor with IC50 values of 13 nM and 59 nM, respectively. TBK1/IKKε-IN-4 shows 100- to 1000-fold less activity against other protein kinases including PDK1, PI3K family members and mTOR[1]. TBK1/IKKε-IN-4 (Compound II; 96 hours; A549 andHCC44 cells) treatmentdisplays selective toxicity in TBK1-dependent cancer cell lines (IC50 of ~ 4.2 μM for H441 cells and IC50 of ~0.4 μM for A549 cells)[1].TBK1/IK... | |||
T79723 |
PDK-IN-2
|
Others | Others |
PDK-IN-2(Compound 1F)是一种具有IC50为68 nM的PDK抑制剂。该化合物能够抑制PDK1和PDK4在细胞内的表达,增强线粒体生物能并降低糖酵解表型,同时诱导细胞走向线粒体途径的apoptosis。此外,PDK-IN-2在4T1同基因小鼠模型中能够有效抑制肿瘤生长。 | |||
T81446 |
PKM2 activator 6
|
Others | Others |
PKM2 activator 6 (Compound Z10) 作为一种PKM2激活剂同时抑制PDK1,其KD值分别为121 μM和19.6 μM。该化合物诱导结直肠细胞发生凋亡,并显著抑制细胞增殖与迁移。通过抑制糖酵解作用,PKM2 activator 6降低DLD-1、HCT-8、HT-29、MCF-10A细胞的增殖,IC50值分别为10.04、2.16、3.57、66.39 μM。 | |||
T35491 |
3,5-dimethyl PIT-1
|
Others | Others |
PtdIns-(3,4,5)-P3 (PIP3) serves as an anchor for the binding of signal transduction proteins bearing pleckstrin homology (PH) domains such as phosphatidylinositol 3-kinase (PI3K) or PTEN. Protein binding to PIP3 is important for cytoskeletal rearrangement and membrane trafficking and initiates an intricate signaling cascade that has been implicated in cancer. 3,5-dimethyl PIT-1 is a dimethyl analog of PIT-1, the selective inhibitor of PIP3/Akt PH domain binding, that is designed for more favorab... | |||
T84871 |
Emetine hydrochloride
NSC 33669 |
Others | Others |
Emetine hydrochloride (NSC 33669),一种从ipecac根部提取的生物碱,用于临床上作为催吐及抗原生动物药物。它能够降低HIFs (hypoxia-inducible factors; HIF-1α and HIF-2α)、PDK1、RhoA、Rho-kinases (ROCK1 and ROCK2)和BRD4,抑制细胞自噬,并展现抗疟疾、抗病毒、抗细菌及抗变形虫效果。 | |||
TQ0313 |
NVP-BAG956
BAG956 |
PI3K | PI3K/Akt/mTOR signaling |
NVP-BAG956 is an ATP-competitive PI3K inhibitor (IC50s: 34/56/112/444 nM for PI3Kδ/PI3Kα/PI3Kγ/PI3Kβ). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0809 |
Dicoumarol
Dicumarol,双羟香豆素,双香豆素 |
Dehydrogenase; NADPH; PDK | Metabolism; PI3K/Akt/mTOR signaling |
Dicoumarol (Dicumarol) 是一种 NAD(P)H: 醌氧化还原酶 1 和PDK1的抑制剂,它们的IC50值分别为 0.37 和 19.42 μM。 | |||
T3895 |
Polyphyllin I
重楼皂苷I,重楼皂甙 |
Apoptosis; Akt; JNK; PDK; mTOR; Autophagy | Apoptosis; Autophagy; Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling |
Polyphyllin I 是从七叶一枝花中提取的生物活性成分,具有很强的抗肿瘤活性。它是 JNK 信号通路的激活剂,也是 PDK1/Akt/mTOR 信号传导的抑制剂。它诱导自噬,G2/M 期阻滞和细胞凋亡。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02469 |
PDK1 Protein, Mouse, Recombinant (His)
Pdk1,Pyruvate dehydrogenase kinase isoform... |
Mouse | Baculovirus Insect Cells |
PDK1 Protein, Mouse, Recombinant (His) is expressed in Baculovirus insect cells with N-10xHis tag. The predicted molecular weight is 48.7 kDa and the accession number is Q8BFP9. | |||
TMPY-04568 |
PDK1 Protein, Human, Recombinant (His)
pyruvate dehydrogenase kinase, isozyme 1,PDHK1<... |
Human | Baculovirus Insect Cells |
Pyruvate dehydrogenase kinase, isozyme 1, also known as [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial and PDK1, is a member of the PDK / BCKDK protein kinase family. PDK-1 is expressed predominantly in the heart. It contains one histidine kinase domain. Pyruvate dehydrogenase kinase (PDK) isoforms are molecular switches that downregulate the pyruvate dehydrogenase complex (PDC) by reversible phosphorylation in mitochondria. An inhibitory effect of lipoic acid on PDKs would... | |||
TMPY-04392 |
RSK3 Protein, Human, Recombinant (GST)
HU-2,ribosomal protein S6 kinase, 90kDa, polypeptide 2,S6K-α... |
Human | Baculovirus Insect Cells |
Ribosomal protein S6 kinase alpha-2, also known as 9 kDa ribosomal protein S6 kinase 2, MAP kinase-activated protein kinase 1c, MAPK-activated protein kinase 1c, Ribosomal S6 kinase 3, RSK-3, RPS6KA2 and MAPKAPK1C, is a nucleus protein that belongs to the protein kinase superfamily, AGC Ser/Thr protein kinase family and S6 kinase subfamily. RPS6KA2 / RSK-3 is expressed in many tissues. Highest expression is in lung and skeletal muscle. The expression of RPS6KA2 reduced proliferation, caused G1 a... |